Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Library

PeptiMed

PeptiMed, Inc.: A biotech firm developing targeted therapeutic drugs for advanced cancers in the US.

Madison, WI, US🇺🇸

Founded

Loading

PeptiMed Website, Blog & Press Pages - aVenture

PeptiMed - Library

peptimed.comCrawled Oct 15, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

Cagrilintide/product/cagrilintide
Cagrilintide for Professional Use Only, suitable for appetite, metabolic, and gastric motility research. Not for human use.
CJC-1295 (No DAC) 5mg – Short-Acting GHRH Analog for Pulsatile GH Research/product/cjc-1295-no-dac
CJC-1295 No DAC for professional research on pulsatile GH release, pituitary signaling, IGF-1 modulation, endocrine aging, and combination GHRP pathways.
Copper Glow – Advanced Peptide Firming & Renewal Cream/product/copper-glow
Copper Glow peptide cream with GHK-Cu and SNAP-8 supports visibly firmer, smoother, brighter skin with daily use. Lightweight and ideal for post-treatment care.
Glp-2tz 30mg/product/gl-2tz-30mg
GLP-2TZ is a dual-pathway research peptide used in professional studies of incretin-related signaling, metabolic pathways, and glucose-response modeling. It is also used in nutrient-signaling and energy-balance research.

About

1 page

About/about
PeptiMed supplies physicians, clinics, and qualified medical professionals with peptides, medical-use devices, and supportive solutions in longevity, aesthetics, metabolic health, and sexual wellness. Its products are compounded in a U.S. facility following GMP protocols.

Contact

1 page

Contact Us/contact-us
The page provides a way to contact the team for support or inquiries.

Homepage

1 page

Homepage/
Peptides Designed for Professionals

Privacy

1 page

Privacy Policy/privacy-policy
PeptiMed's privacy policy describes how it collects, uses, and discloses personal information related to visits, service use, purchases, and communications about the Site.